Brief: BioSyent Signs Exclusive Technology Agreement
13/07/2021 13:37
July 13 (Reuters) - Biosyent Inc RX.V :
* BIOSYENT INC - UNIT TO LICENSE TECHNOLOGY APPLICATION TO
SUPPORT
BETTER TREATMENT OUTCOMES FOR PATIENTS WITH IRON DEFICIENCIES IN
CANADA, CO'S INTERNATIONAL MARKETS
Source text for Eikon: ID:nGNXbVk0Sb
Further company coverage: RX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid